Mylan Can't Exclude Ex-CEO From EpiPen Antitrust Trial
By Bryan Koenig · January 6, 2022, 5:20 PM EST
A Kansas federal judge Wednesday rejected Mylan's bid to spare a former CEO from the late January trial in a massive antitrust class action accusing the drugmaker of unlawfully blocking generic...
To view the full article, register now.